Clinical Trial

A Food-Effect Study of CX11 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-08; most recent amendment 2026-03-25.
Status change: Not Yet Recruiting → Recruiting 2026-03-25
Trial Details
NCT Number NCT07349381
Lead Sponsor Vincentage Pharma Co., Ltd
Collaborators: Corxel Pharmaceuticals
Conditions Obesity & Overweight, Type 2 Diabetes
Enrollment 32 participants
Start Date 2026-03-04
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27